Pharmeca.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Mylan Ireland Limited, against the decision of the State Institute for Drug Control from 2. 6. 2020, under the no. SUKLS109849/2020:

• the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

Published 10. 9. 2020.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Bristol-Myers Squibb/Pfizer EEIG, against the decision of the State Institute for Drug Control from 29. 9. 2017, under the no. SUKLS240183/2016 - I. under article 90 paragraph 4 in connection with article 66 paragraph 2 of the Administrative Code the operative part 4, 5, 8 and 10 of the decision under appeal is dismissed and the proceedings are terminated II. Under article 90 paragraph 1 letter b) of the Administrative Code  the decision is reversed and the matter is referred back to the State Institute for Drug Control for reappraisal.

More info MZCR.cz (czech version only)

Review procedure in the case a decision of the Ministry of Health of the Czech Republic from 9. 4. 2020, reference no. MZDR 50688/2019-2/CAU, under the no. L71/2019, against the decision of the State Institute for Drug Control from 30. 9. 2019, under the no. SUKLS215786/2013 - under article 97 paragraph 1 of the Administrative Code the review are terminated.

More information: MZCR.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Bristol-Myers Squibb/Pfizer EEIG, against the decision of the State Institute for Drug Control from 13. 5. 2020, under the no. SUKLS215786/2013 - 

The appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Mylan Ireland Limited, against the decision of the State Institute for Drug Control from 3. 6. 2020, under the no. SUKLS116627/2020 - The appeal is dismissed. 

More information: MZCR.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Chiesi Pharmaceuticals GmbH, Novartis Europharm Limited, Novartis s.r.o., against the decision of the State Institute for Drug Control from 20. 9. 2017, under the no. SUKLS156890/2013 - The decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.

More information: MZCR.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Roche Registration GmbH, against the decision of the State Institute for Drug Control from 22. 5. 2020, under the no. SUKLS121963/2020 - 

The appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Takeda Manufacturing Austria AG, against the decision of the State Institute for Drug Control from 19. 6. 2020, under the no. SUKLS147897/2020 - The appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz